Can You Take Amitriptyline with Fluoxetine?
A plain-English look at the moderate interaction between Amitriptyline (ENTRIP) and Fluoxetine (FLUOTEX) — what it means, why it happens, and what to talk to your doctor or pharmacist about.
Combining Amitriptyline (ENTRIP) with Fluoxetine (FLUOTEX) is a moderate interaction requiring caution and monitoring. Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
Not sure about your specific combination? Check it in the Drug Interaction Checker →
Key Takeaways
- Interaction severity: Moderate
- Risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.
- Mechanism: Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
- Amitriptyline: S4 in Australia, moderate risk
- Fluoxetine: S4 in Australia, low risk
- Claims action: Monitor and document. Request clinical justification if combination is ongoing.
Amitriptyline vs Fluoxetine at a Glance
| Property | Amitriptyline | Fluoxetine |
|---|---|---|
| Brand names | ENTRIP, Amitriptyline Lupin, APX-Amitriptyline | FLUOTEX, Blooms the Chemist Fluoxetine, APO-Fluoxetine |
| Drug class | opioid | antidepressant |
| Risk level | moderate | low |
| TGA Schedule (AU) | S4 | S4 |
Why Is This Combination Dangerous?
Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
Regulatory Guidance by Jurisdiction
Australia TGA / SIRA / WorkSafe
The TGA and Australian Medicines Handbook classify this as a moderate drug interaction requiring monitoring and clinical review.
United Kingdom NICE / MHRA / FPM
NICE guidelines advise against combining multiple serotonergic medications due to the risk of serotonin syndrome. For personal injury claims, antidepressant prescribing should be reviewed for injury relatedness and appropriateness.
United States FDA / CDC / State WC
The FDA has issued Drug Safety Communications about the risk of serotonin syndrome with concurrent use of serotonergic medications. Workers compensation nurse case managers should flag this combination for prescriber review.
What Claims Professionals Should Do
- Document the combination in the claim file with a note on interaction risk
- Request clinical justification from the prescriber at the next review
- Monitor for adverse effects including excessive sedation, falls, and cognitive impairment
- Assess injury relatedness of both medications to the compensable condition
- Review at next claim assessment and consider whether the combination is still clinically appropriate
Clinical reference
A clinical summary of Amitriptyline and Fluoxetine drawn from regulator advisories, national guidelines, and authoritative drug references. Read this if you want the deeper clinical picture before talking to your prescriber or pharmacist.
Severity assessment
Major. Coadministration significantly increases amitriptyline plasma concentrations and potentiates serotonin syndrome risk, a serious and potentially fatal condition [1] [2].
Mechanism (plain English)
Fluoxetine, an SSRI, inhibits CYP2D6, the enzyme metabolizing amitriptyline (a TCA). This raises amitriptyline levels, increasing toxicity risk. Both drugs elevate brain serotonin; their combined effect can cause excessive serotonin, leading to serotonin syndrome [1] [2].
Evidence level
Regulator-flagged. This interaction is a major concern for regulatory bodies like the FDA and is documented in clinical guidelines such as the NICE British National Formulary [1] [2].
Top regulator advisories (cite verbatim or close paraphrase)
- TGA (Australia): No pair-specific public advisory. General antidepressant product information advises caution with co-administration of other serotonergic agents [3].
- MHRA / NICE (UK): The NICE BNF states fluoxetine increases amitriptyline exposure, necessitating monitoring for toxicity and dose adjustment. It also notes additive CNS depressant effects and increased hyponatremia risk [2].
- FDA / CDC (US): The FDA label for PROZAC (fluoxetine) warns of serotonin syndrome risk with other serotonergic agents, including TCAs. It highlights fluoxetine's potent CYP2D6 inhibition and advises monitoring TCA levels [1].
- EMA (Europe): No specific EMA advisory for this exact pair was found. EMA guidelines generally emphasize careful consideration of drug interactions involving CYP enzymes and serotonergic effects.
Clinical risk factors that elevate the danger
Hepatic impairment and elderly patients face increased risk due to altered drug metabolism. Patients on multiple concomitant medications, especially other serotonergic agents or CYP2D6 inhibitors, also have elevated danger. Individuals with a history of seizures or cardiac conditions are more susceptible to severe adverse effects [1].
What a patient should be told
- Understand the risk: Combining these medications can increase amitriptyline levels and raise the risk of serotonin syndrome. Watch for confusion, agitation, rapid heart rate, sweating, muscle stiffness, and tremors.
- Do not stop suddenly: Never stop or change doses without consulting your doctor to avoid withdrawal or worsening conditions.
- Watch for warning signs: Report any unusual symptoms to your doctor immediately, especially when starting or changing doses.
- Discuss alternatives: Talk to your doctor or pharmacist about the safest treatment options.
- Seek urgent care: If you experience high fever, severe muscle rigidity, or significant mental changes, seek immediate medical attention.
Top 3 sources (with full citation)
- U.S. Food and Drug Administration (FDA): "PROZAC (fluoxetine capsules) for oral use, PROZAC (fluoxetine delayed-release capsules) for oral use." FDA Prescribing Information, revised January 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s108lbl.pdf
- NICE British National Formulary (BNF): "Fluoxetine Interactions." NICE, accessed June 1, 2026. https://bnf.nice.org.uk/interactions/fluoxetine/
- Drugs.com: "Interactions between Amitriptyline and Fluoxetine." Drugs.com, accessed June 1, 2026. https://www.drugs.com/drug-interactions/amitriptyline-with-fluoxetine-168-0-1115-0.html?professional=1
Notes for the reviewing pharmacist
This interaction is well-established, primarily due to fluoxetine's potent CYP2D6 inhibition, elevating amitriptyline levels, and additive serotonergic effects increasing serotonin syndrome risk. Due to fluoxetine's long half-life, risk persists for weeks post-discontinuation. Close monitoring of TCA plasma levels and clinical signs of toxicity (e.g., anticholinergic effects, CNS irritability, altered consciousness, myoclonus) and serotonin syndrome is crucial. Dosage adjustments of amitriptyline are often necessary. Consider genetic CYP2D6 metabolizer status. Patient education on warning signs is paramount.
Source metadata JSON
Check this medication against your full medication list
Check all interactions for Amitriptyline and Fluoxetine across your claimant's full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.